2018
-
James P. Allison and Tasuku Honjo Jointly Awarded the Nobel Prize for Discovering Immunotherapy
Posted: December 2018 James P. Allison, PhD, and Tasuku Honjo, PhD, MD, were jointly awarded the 2018 Nobel Prize in Physiology or Medicine for their breakthrough accomplishments in cancer immunotherapy, […]
-
Fighting the Tobacco Scourge: Implementation of Tobacco-Control Measures Begets Public Health Success
By Jeffrey Drope, PhD; Cary Adams, MBA; Clifford E. Douglas, JD; Jacqui Drope, MPH; and Sonali Johnson, PhD Posted: December 2018 Clifford E. Douglas There is clear evidence of success in […]
-
Inaugural LATAM Awards
Posted: December 2018 The IASLC Latin America Conference on Lung Cancer in August featured a new awards presentation. The awards, sponsored by the IASLC Latin America Group (LATAM) were, in […]
-
Highlights from the NCI Post-Treatment Surveillance Workshop
Posted: December 2018 The National Cancer Institute (NCI) held a Post-Treatment Surveillance Workshop at the Shady Grove Campus this past March. In addition to lung cancer, the workshop focused on […]
-
2018 ASTRO Guideline for Palliative Thoracic Radiation Therapy for NSCLC: The Balance Between Curative and Palliative Radiotherapy
By Shalini K. Vinod, MBBS, MD Posted: October 2018 The standard of care for patients with inoperable stage III NSCLC is curative radiotherapy and concurrent chemotherapy.1 However, there are numerous […]
-
The Vital and Evolving Role of Bronchoscopic Technologies in Lung Cancer Management
By Andrew R. Haas, MD, PhD Posted: October 2018 Lung cancer remains the leading global cause of cancer-related mortality.1 Due to the lack of symptoms at the time early-stage disease […]
-
Top Science in Lung Cancer Featured at WCLC 2018
By Kara Nyberg, PhD Posted: October 2018 The Presidential Symposium at the IASLC World Conference on Lung Cancer 2018 (WCLC) showcased the top five scientific abstracts highlighting progress in detecting […]
-
Living in the “Gray Zone”: Entering a New Age in Radiation Therapy for Patients with Lung Cancer
Posted: October 2018 Patients with stage III or more advanced lung cancer tend to be older and less healthy than patients with other stage III cancers. Because of this, selection […]
-
A Review of CancerSEEK
By Pierre P. Massion, MD Posted: October 2018 Early detection is key to disease management. For example, there are numerous data in hypertension, diabetes, coronary artery disease, and renal dysfunction […]
-
The Treatment of Patients with Oligometastatic Lung Cancer
By Anne-Marie C. Dingemans, MD, PhD, and Lizza E.L. Hendriks, MD, PhD Posted: October 2018 Patients with stage IV NSCLC are generally viewed as having incurable disease; however, for years, […]
View ILCN Archives
Provider Resources